American Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,970
Closed -$237K 173
2026
Q1
$237K Buy
1,970
+12
+0.6% +$1.39K 0.03% 145
2025
Q4
$206K Buy
+1,958
New +$184K 0.03% 155
2024
Q4
Sell
-1,980
Closed -$225K 152
2024
Q3
$225K Buy
1,980
+9
+0.5% +$1.07K 0.03% 135
2024
Q2
$244K Buy
1,971
+8
+0.4% +$1.03K 0.03% 129
2024
Q1
$259K Buy
1,963
+10
+0.5% +$1.23K 0.04% 126
2023
Q4
$213K Sell
1,953
-39
-2% -$4.05K 0.03% 131
2023
Q3
$205K Buy
1,992
+9
+0.5% +$970 0.03% 126
2023
Q2
$229K Buy
1,983
+10
+0.5% +$1.14K 0.04% 123
2023
Q1
$210K Buy
1,973
+9
+0.5% +$972 0.03% 119
2022
Q4
$218K Buy
+1,964
New +$201K 0.04% 116

Other funds holding MRK

American Financial Advisors's MRK Position: Q2 2026 in Review

American Financial Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 1,970 shares — an estimated $237K sold.

American Financial Advisors first reported a position in MRK in Q4 2022 and held it in 10 quarters. The position peaked at $259K in Q1 2024. 1,598 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • American Financial Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • American Financial Advisors sold 1,970 Merck shares in Q2 2026, an estimated $237K.
  • American Financial Advisors first reported a position in Merck in Q4 2022 and held it in 10 quarters.
  • American Financial Advisors's Merck position peaked at $259K in Q1 2024.
  • 1,598 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on American Financial Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.